Linking the p53 tumour suppressor pathway to somatic cell reprogramming - Test2 - elhamkhani - TriplyDB

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

http://www.wikidata.org/entity/Q29616507

about

Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research Gingival fibroblasts as a promising source of induced pluripotent stem cells Primordial germ cells in mice Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies Tumor suppressors: enhancers or suppressors of regeneration?Regulation of pluripotency and self- renewal of ESCs through epigenetic-threshold modulation and mRNA pruning Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective Direct cell reprogramming is a stochastic process amenable to acceleration Induced neuronal cells: how to make and define a neuron Dissecting microRNA-mediated regulation of stemness, reprogramming, and pluripotency Pluripotent Stem Cells: Current Understanding and Future Directions Hematopoietic Stem and Immune Cells in Chronic HIV Infection Eradication of therapy-resistant cancer cells in gastrointestinal organs Energy metabolism plasticity enables stemness programs Reprogramming of gastrointestinal cancer cells The impact of cellular senescence in cancer therapy: is it true or not?MYC and the art of microRNA maintenance Concise review: Oct4 and more: the reprogramming expressway Metastatic cancer stem cells: from the concept to therapeutics A poor imitation of a natural process: a call to reconsider the iPSC engineering technique Shared mechanisms in stemness and carcinogenesis: lessons from oncogenic viruses Echoes of a distant past: The cag pathogenicity island of Helicobacter pylori microRNAs as novel regulators of stem cell pluripotency and somatic cell reprogramming The genomic stability of induced pluripotent stem cells The roles of the reprogramming factors Oct4, Sox2 and Klf4 in resetting the somatic cell epigenome during induced pluripotent stem cell generation Concise review: Generation of neurons from somatic cells of healthy individuals and neurological patients through induced pluripotency or direct conversion The cell cycle and pluripotency Overcoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and quality Direct lineage conversion: induced neuronal cells and induced neural stem cells Cellular reprogramming in skin cancer dp53 Restrains ectopic neural stem cell formation in the Drosophila brain in a non-apoptotic mechanism involving Archipelago and cyclin E Turning terminally differentiated skeletal muscle cells into regenerative progenitors.Genetic background affects induced pluripotent stem cell generation Examination of the expanding pathways for the regulation of p21 expression and activity.Caught in the cross fire: p53 in inflammation.Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs

P2860

Q21183968-84CEF4B9-6689-4B43-A10D-FC401684DDB7 Q21560780-C8969AC4-416A-4650-A73F-49C1DEAC00C2 Q21562159-673CAA21-39DA-41DA-810F-1BE0DCACEB16 Q22065789-04AC4B35-1098-4D25-B82E-2CB44AEC3032 Q24337508-22CE58B8-FE24-45A0-AD69-1BE361BA1F05 Q24612314-BAEF01DA-56A5-4381-AA75-62AD76B577D0 Q24617141-01013F85-8C20-4238-9A66-788744889FE8 Q24618747-F7DA629B-D328-4F61-A71F-C380A857DBC9 Q24619000-C10E92C7-85EA-4787-9E6B-69F7C431DD8F Q24624032-497D667F-5E52-4A49-BBC9-28D647DDCE78 Q24633489-0AD917B2-5EF6-4285-8184-9D4383F57CD7 Q24644898-FDFECF2F-56FF-43E0-865B-D54C3C3A9A60 Q26269839-0511791A-7681-4457-B789-B68C7C4B4B2A Q26752448-63ACE839-26EE-4CB5-8065-ECB4619804C8 Q26769981-B7C12A31-FEFB-4A8D-9A56-6E8D78C1BBE8 Q26795450-B4477BD7-02C5-427C-B777-352282338A4D Q26822685-5BE68A29-61E1-4F17-B227-3E52D30805C0 Q26822945-6C5CC741-726F-45A8-8541-8C6A988D8049 Q26824284-A7537028-18FA-4EC8-BA36-843668C61958 Q26825221-D732A564-E0BE-416E-A384-2B985031BD73 Q26825457-A541A8E9-C203-47DB-AD09-023698DA8EB4 Q26827123-AE7F2329-296B-4830-A0D7-5377B471325A Q26850739-EBA13807-6765-4BD0-B6EF-E7C5BB464AF0 Q26851933-C9CA2813-04B2-42D5-A351-9EBB88D97FA0 Q26863339-9968E5FC-FDD6-433D-AA30-01CAC1F7DB7A Q26865877-2D86DBE5-632A-4D2F-9A49-4CA0579417E8 Q26997070-88A8194D-60A6-4D13-A145-D14A997AF545 Q26998764-1C43672D-65FD-4E56-8395-870D7D7DD7F0 Q26999027-9E62DD81-6245-4EA3-9812-D26116CF4262 Q27004350-9A5073C5-40A0-4385-B5B9-A686C36E6E83 Q27009037-C101388F-6760-41BD-90F7-F43E545D0702 Q27014026-B56B3367-2EA0-4B0A-8988-9B2CA6BF77BD Q27025605-E2B0DEA2-7CB1-45E1-8696-1EAEB79F9F9E Q27027468-839876E1-5C9A-48C9-95D8-0EDD8F641714 Q27311610-0A6180CC-BAFC-44E1-89E2-A6C5AD4E520A Q27323653-A0C09A9A-A8A9-46BF-86F6-1048AF0164B1 Q27499837-EA4991EE-8182-493C-BF24-2DCF34E3D9D0 Q27692024-43218389-96B7-439D-A5D5-873B43C5A6BE Q27692076-E8C8A184-0EAE-4551-AEF3-85728BA4C657 Q28067268-E6A3AB7A-0696-4B1D-8598-6F4500C4D200

P2860

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

http://www.wikidata.org/entity/Q29616507

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

@ast

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

@en

type

label

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

@ast

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

@en

prefLabel

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

@ast

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

@en

P1433

Q29616507-2F407253-395C-4E1F-A523-198A57C903DE

P1476

Q29616507-2F68DCB4-9FB3-4FD8-A951-D3E33AE5D133

P2093

Q29616507-06AEA636-473E-4EC4-9EB4-8E837C13BAE7

Q29616507-632DE28F-39C2-4CA0-A8E4-9FB5850773C6

Q29616507-9EA06E99-F409-4F22-96BF-D78ECC26F144

Q29616507-AFDFBC3B-1DD7-4EF5-A0FF-E0BC336E6F65

Q29616507-B204E09F-B36E-4ECF-9BBD-D7872FB1875C

Q29616507-E8ACDD17-60D7-49BB-AB41-86EE33CC8D30

Q29616507-F7D11103-E0D2-46F4-85AD-73AC1ADF5AEF

Q29616507-F819AFF5-E403-4A99-9A62-D16A1BE71AA9

P2860

Q29616507-080A9372-66C7-47E8-9BDD-BD17F506D27C

Q29616507-09E89496-450E-46A1-8F88-70C91A226AD0

Q29616507-177D5B16-CCE1-4096-AE8F-3D4AB381BAF8

Q29616507-1C998B49-DA0E-4DD9-B6B3-72EF96E4FD66

Q29616507-1DE16E58-2AB2-4EB8-B828-81F22A764DD2

Q29616507-2EA47D51-D0B8-4913-8BAC-890B2F029D4D

Q29616507-3259BB6A-B7FD-4240-AC2F-D0CE6B71B6C0

Q29616507-33E63FF0-152F-4B1C-837C-8C060C11EC10

Q29616507-347B0C56-03B2-40EF-8FF2-EECB03EC0850

Q29616507-3C4D51C4-854D-4F82-9ECC-8B80F77C5CB3

P2888

Q29616507-48EFF23C-DF91-45D6-944A-7612545A7361

P304

Q29616507-E21347DB-C976-4ACA-9919-3F7B7956302F

P31

Q29616507-EA07CA74-D3F3-49AF-89EC-EA088496A911

P3181

Q29616507-0DDA09A5-7E1A-4B27-8282-73FA3B509C02

P356

Q29616507-436D5540-352C-4BD2-B45B-FBF7172A62C7

P407

Q29616507-49FA420E-C60D-4A69-9944-EDC67A9B9528

P433

Q29616507-DD87412E-5B57-4D01-80FA-67C7B2A046CB

P478

Q29616507-479CFD2A-B7B0-4A59-A0E6-5BDB3C5735A1

P577

Q29616507-A60C57EF-57E4-492E-8E7B-2CAF36637BF2

P5875

Q29616507-A26E55BC-9258-4A4C-B8D8-57B5E51BF0D6

P6179

Q29616507-36516A62-5B58-4D32-87C1-8C8124501579

P698

Q29616507-72B46578-7B4D-4265-9B87-F1B0B11E5EB4

P932

Q29616507-514A6B8F-039F-4DA5-881E-B06BD821DAEC

P3181

P356

P1433

P1476

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

@en

P2093

Izpisúa Belmonte JC

http://www.w3.org/2001/XMLSchema#string

Kawamura T

http://www.w3.org/2001/XMLSchema#string

Menendez S

http://www.w3.org/2001/XMLSchema#string

Morera LB

http://www.w3.org/2001/XMLSchema#string

Raya A

http://www.w3.org/2001/XMLSchema#string

Suzuki J

http://www.w3.org/2001/XMLSchema#string

Wahl GM

http://www.w3.org/2001/XMLSchema#string

Wang YV

http://www.w3.org/2001/XMLSchema#string

P2860

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

Induced pluripotent stem cell lines derived from human somatic cells

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Generation of germline-competent induced pluripotent stem cells

Reprogramming of human somatic cells to pluripotency with defined factors

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression

P2888

P304

1140-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

235933

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE08311

http://www.w3.org/2001/XMLSchema#string

P407

P433

7259

http://www.w3.org/2001/XMLSchema#string

P478

460

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26729783

http://www.w3.org/2001/XMLSchema#string

P6179

1040491383

http://www.w3.org/2001/XMLSchema#string

P698

19668186

http://www.w3.org/2001/XMLSchema#string

P932

2735889

http://www.w3.org/2001/XMLSchema#string